Effects of hypoglycemia on health-related quality of life, treatment satisfaction and healthcare resource utilization in patients with type 2 diabetes mellitus

Diabetes Research and Clinical Practice

Volumn 91, Issue 3, 2011, Pages 363-370

  Williams, Setareh A ^a   Pollack, Michael F ^a   DiBonaventura, Marco ^b  

^a ASTRAZENECA   (United Kingdom)

^b KANTAR HEALTH   (United States)

Author keywords

Diabetes mellitus; Health related quality of life; Oral antidiabetic; Treatment satisfaction

Indexed keywords

ORAL ANTIDIABETIC AGENT; SULFONYLUREA;

ADULT; ANXIETY; ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; DEPRESSION; EMERGENCY CARE; EMERGENCY WARD; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEALTH CARE UTILIZATION; HEALTH SURVEY; HUMAN; HYPOGLYCEMIA; INTERNET; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; ONLINE ANALYSIS; PAIN ASSESSMENT; PATIENT SATISFACTION; PHYSICAL ACTIVITY; PHYSICAL MOBILITY; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM; SELF REPORT;

ADULT; AGED; DATA COLLECTION; DIABETES MELLITUS, TYPE 2; HEALTH RESOURCES; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; MIDDLE AGED; PATIENT SATISFACTION; QUALITY OF LIFE;

EID: 79952361620     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2010.12.027     Document Type: Article

References (24)

1. Mainous A.G., Baker R., Koopman R.J., Saxena S., Diaz V.A., Everett C.J., et al. Impact of the population at risk of diabetes on projections of diabetes burden in the United States: an epidemic on the way. Diabetologia 2007, 50(5):934-940.
2. Centers for disease control and prevention, National Diabetes Factsheet 2007, ; 2007 [accessed 9.10.09]. http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2007.pdf.
3. Pouwer F., Hermanns N. Insulin therapy and quality of life: a review. Diabet Metab Res Rev 2009, 25(Suppl. 1):S4-S10.
4. American Diabetes Association Standards of medical care in diabetes - 2009. Diabet Care 2009, 32(Suppl. 1):S13-S61.
5. Cheung B.M., Ong K.L., Cherny S.S., Sham P.C., Tso A.W., Lam K.S. Diabetes prevalence and therapeutic target achievement in the United States, 1999-2006. Am J Med 2009, 122(5):443-453.
6. Rodbard H.W., Jellinger P.S., Davidson J.A., Einhorn D., Garber A.J., Grunberger G., et al. Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control. Endocr Pract 2009, 15(6):540-559.
7. Amiel S.A., Dixon T., Mann R., Jameson K. Hypoglycaemia in type 2 diabetes. Diabet Med 2008, 25(3):245-254.
8. Gabriely I., Shamoon H. Hypoglycemia in diabetes: common, often unrecognized. Cleve Clin J Med 2004, 71(4):335-342.
9. Childs B.P., Clark N.G., Cox D.J., Cryer P.E., Davis S.N., DiNardo M.M., et al. Defining and reporting hypoglycemia in diabetes - a report from the American Diabetes Association Workgroup on Hypoglycemia. Diabe Care 2005, 28(5):1245-1249.
10. Hay L. Unrecognized hypo and hyperglycemia in well-controlled patients with type 2 diabetes mellitus: the results of continuous glucose monitoring. Diab Technol Ther. 2003, 5(1):19-26.
11. Miller C.D., Phillips L.S., Ziemer D.C., Gallina D.L., Cook C.B., El-Kebbi I.M. Hypoglycemia in patients with type 2 diabetes mellitus. Arch Intern Med 2001, 161(13):1653-1659.
12. Marrett E., Stargardt T., Mavros P., Alexander C.M. Patient-reported outcomes in a survey of patients treated with oral antihyperglycaemic medications: associations with hypoglycaemia and weight gain. Diabet Obes Metab 2009, 11(12):1138-1144.
13. Guisasola F.A., Povedano S.T., Krishnarajah G., Lyu R., Mavros P., Yin D. Hypoglycaemic symptoms, treatment satisfaction, adherence and their associations with glycaemic goal in patients with type 2 diabetes mellitus: findings from the Real-Life Effectiveness and Care Patterns of Diabetes Management (RECAP-DM) Study. Diabet Obes Metab 2008, 10(Suppl. 1):25-32.
14. Davis R.E., Morrissey M., Peters J.R., Wittrup-Jensen K., Kennedy-Martin T., Currie C.J. Impact of hypoglycaemia on quality of life and productivity in type 1 and type 2 diabetes. Curr Med Res Opin 2005, 21(9):1477-1483.
15. Bullano M.F., Al-Zakwani I.S., Fisher M.D., Menditto L., Willey V.J. Differences in hypoglycemia event rates and associated cost-consequence in patients initiated on long-acting and intermediate-acting insulin products. Curr Med Res Opin 2005, 21(2):291-298.
16. Gazmararian J.A., Ziemer D.C., Barnes C. Perception of barriers to self-care management among diabetic patients. Diabet Educ 2009, 35(5):778-788.
17. Charlson M.E., Pompei P., Ales K.L., MacKenzie C.R. A new methods of classifying prognostic comorbidity in longitudinal studies: develop and validation. J Chron Dis. 1987, 40(5):373-383.
18. Morisky D.E., Green L.W., Levine D.M. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986, 24(1):67-74.
19. Brod M., Skovlund S.E., Wittrup-Jensen K.U. Measuring the impact of diabetes through patient report of treatment satisfaction, productivity and symptom experience. Qual Life Res 2006, 15(3):481-491.
20. EuroQoL Group EuroQol - a new facility for the measurement of health-related quality of life. Health Policy 1990, 16(3):199-208.
21. Walters S.J., Brazier J.E. Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D. Qual Life Res 2005, 14(6):1523-1532.
22. Pelletier E.M., Smith P.J., Boye K.S., Misurski D.A., Tunis S.L., Minshall M.E. Direct medical costs for type 2 diabetes mellitus complications in the US commercial payer setting: a resource for economic research. Appl Health Econ Health Policy 2008, 6(2-3):103-112.
23. Pollack M., Waterman F., Bolge S.C., Williams S.A. Satisfaction with diabetes treatments: impacts on patient health-related quality of life and productivity. Poster presented at International Society for Pharmacoeconomics and Outcomes Research 2009.
24. Pollack M., Bolge S.C., Williams S.A., Williams S.A. The association between patient-reported diabetes symptoms and tolerability issues of oral antidiabetic agents on work and life productivity. Poster presented at International Society for Pharmacoeconomics and Outcomes Research 2009.